diazoxide has been researched along with Hepatocellular Carcinoma in 3 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YS | 1 |
| Vachon, A | 1 |
| Noel, G | 1 |
| Gauthier, J | 1 |
| Tete, R | 1 |
| Berthou, JD | 1 |
| Paraf, A | 1 |
| Rautureau, J | 1 |
| Benabadji, A | 1 |
3 other studies available for diazoxide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Mechanism of apoptosis induced by diazoxide, a K+ channel opener, in HepG2 human hepatoma cells.
Topics: Apoptosis; Calcium Channels; Calcium Signaling; Carcinoma, Hepatocellular; Cell Line, Tumor; Diazoxi | 2004 |
[Current drug therapy of organic hypoglycemia].
Topics: Adenoma, Islet Cell; Carcinoma, Hepatocellular; Diazoxide; Female; Glucagon; Humans; Hypoglycemia; L | 1968 |
[Hypoglycemia and primary liver cancer. Hormone levels. Action of diazoxide].
Topics: Adult; Carcinoma, Hepatocellular; Diazoxide; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin | 1967 |